Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Letter | 26 April 2024 Diagnostics Tuberculosis Poland Poland: Institute of Tuberculosis and Lung Diseases writes to Danaher to reduce the price of GeneXpert test Photograph by Alexandra Sadokova Press release Press release | 25 April 2024 Transparency Research and development Tuberculosis In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million 6 min Technical brief | 25 April 2024 Transparency Research and development Transparency CORE: Clinical Trial Cost Reporting Toolkit Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min Photo credit: Lana Abramova Press release Press release | 23 April 2024 Diagnostics As Danaher reports quarterly earnings and increased market share for Cepheid’s GeneXpert medical tests, MSF calls on corporation to drop all test prices to $5 for low- and middle-income countries 2 min Letter | 22 April 2024 Diagnostics Hepatitis C HIV/AIDS Ghana Ghana: National AIDS Control Programme letter to Danaher to reduce the price of GeneXpert test Photo credit: MSF/Johnny Vianney Bissakonou Press release Press release | 15 April 2024 Vaccines As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination 3 min Letter | 08 April 2024 Diagnostics Tuberculosis Americas TB Coalition letter to Danaher to reduce the price of GeneXpert test Load More
Letter | 26 April 2024 Diagnostics Tuberculosis Poland Poland: Institute of Tuberculosis and Lung Diseases writes to Danaher to reduce the price of GeneXpert test
Photograph by Alexandra Sadokova Press release Press release | 25 April 2024 Transparency Research and development Tuberculosis In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million 6 min
Technical brief | 25 April 2024 Transparency Research and development Transparency CORE: Clinical Trial Cost Reporting Toolkit
Photo credit: Marta Soszynska/MSF Press release Press release | 24 April 2024 HIV/AIDS Intellectual property and trade Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment 4 min
Photo credit: Lana Abramova Press release Press release | 23 April 2024 Diagnostics As Danaher reports quarterly earnings and increased market share for Cepheid’s GeneXpert medical tests, MSF calls on corporation to drop all test prices to $5 for low- and middle-income countries 2 min
Letter | 22 April 2024 Diagnostics Hepatitis C HIV/AIDS Ghana Ghana: National AIDS Control Programme letter to Danaher to reduce the price of GeneXpert test
Photo credit: MSF/Johnny Vianney Bissakonou Press release Press release | 15 April 2024 Vaccines As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination 3 min
Letter | 08 April 2024 Diagnostics Tuberculosis Americas TB Coalition letter to Danaher to reduce the price of GeneXpert test
